Birdwatch Note
2023-09-02 23:41:02 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
1. Pfizer annual revenue for 2022 was $100.33B, a 23.43% increase from 2021. https://www.macrotrends.net/stocks/charts/PFE/pfizer/revenue 2. AstraZeneca annual revenue for 2022 was $44.351B, a 18.53% increase from 2021. https://www.macrotrends.net/stocks/charts/AZN/astrazeneca/revenue 3. Moderna total revenues of $19.3B in 2022 was a massive increase compared to 2 years ago when it was only 803M. https://www.statista.com/statistics/1107794/revenue-and-net-income-moderna-inc/
Written by EF9E5DBD8B8F36D1B52E7D2D50F3D44A131D305F69B31C43850A80DDE60098B8
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1698116118634758224
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1698118866772414763
- noteId - 1698118866772414763
- participantId -
- noteAuthorParticipantId - EF9E5DBD8B8F36D1B52E7D2D50F3D44A131D305F69B31C43850A80DDE60098B8 Participant Details
- createdAtMillis - 1693698062020
- tweetId - 1698116118634758224
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 1. Pfizer annual revenue for 2022 was $100.33B, a 23.43% increase from 2021. https://www.macrotrends.net/stocks/charts/PFE/pfizer/revenue 2. AstraZeneca annual revenue for 2022 was $44.351B, a 18.53% increase from 2021. https://www.macrotrends.net/stocks/charts/AZN/astrazeneca/revenue 3. Moderna total revenues of $19.3B in 2022 was a massive increase compared to 2 years ago when it was only 803M. https://www.statista.com/statistics/1107794/revenue-and-net-income-moderna-inc/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-09-02 23:41:02 UTC (1693698062020) |
1969-12-31 23:59:59 UTC (-1) |
2023-09-04 02:38:47 UTC (1693795127504) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-09-02 19:30:09 -0500 | Rating Details | |
| 2023-09-02 19:09:50 -0500 | Rating Details | |
| 2023-09-02 19:09:19 -0500 | Rating Details | |
| 2023-09-02 19:01:51 -0500 | Rating Details | |
| 2023-09-02 18:49:07 -0500 | Rating Details | |
| 2023-09-02 18:48:34 -0500 | Rating Details | |
| 2023-09-02 18:45:35 -0500 | Rating Details | |
| 2023-09-02 18:44:21 -0500 | Rating Details | |
| 2023-09-03 17:22:14 -0500 | Rating Details | |
| 2023-09-03 17:11:44 -0500 | Rating Details | |
| 2023-09-03 16:34:34 -0500 | Rating Details | |
| 2023-09-03 13:57:50 -0500 | Rating Details | |
| 2023-09-03 11:47:16 -0500 | Rating Details | |
| 2023-09-03 10:52:05 -0500 | Rating Details | |
| 2023-09-03 10:09:36 -0500 | Rating Details | |
| 2023-09-03 09:11:40 -0500 | Rating Details | |
| 2023-09-03 09:00:07 -0500 | Rating Details | |
| 2023-09-03 07:28:20 -0500 | Rating Details | |
| 2023-09-03 06:40:25 -0500 | Rating Details | |
| 2023-09-03 04:33:53 -0500 | Rating Details | |
| 2023-09-03 04:32:58 -0500 | Rating Details | |
| 2023-09-03 02:53:32 -0500 | Rating Details | |
| 2023-09-03 02:42:31 -0500 | Rating Details | |
| 2023-09-03 02:27:38 -0500 | Rating Details | |
| 2023-09-03 02:00:33 -0500 | Rating Details | |
| 2023-09-03 01:23:11 -0500 | Rating Details | |
| 2023-09-03 01:17:22 -0500 | Rating Details | |
| 2023-09-03 01:04:35 -0500 | Rating Details | |
| 2023-09-03 00:57:42 -0500 | Rating Details | |
| 2023-09-03 00:44:34 -0500 | Rating Details | |
| 2023-09-03 00:24:53 -0500 | Rating Details | |
| 2023-09-03 00:01:44 -0500 | Rating Details | |
| 2023-09-02 23:06:06 -0500 | Rating Details | |
| 2023-09-02 22:37:35 -0500 | Rating Details | |
| 2023-09-02 21:20:27 -0500 | Rating Details | |
| 2023-09-02 21:00:02 -0500 | Rating Details | |
| 2023-09-02 20:53:49 -0500 | Rating Details | |
| 2023-09-02 20:18:12 -0500 | Rating Details | |
| 2023-09-02 19:53:44 -0500 | Rating Details | |
| 2023-09-02 19:52:53 -0500 | Rating Details | |
| 2023-09-02 19:44:59 -0500 | Rating Details | |
| 2023-09-04 08:29:44 -0500 | Rating Details | |
| 2023-09-04 06:35:52 -0500 | Rating Details | |
| 2023-09-13 21:41:17 -0500 | Rating Details |